Screener
Kiniksa Pharmaceuticals International, plc KNSA Accretion (Amortization) of Discounts and Premiums, Investments
Accretion (Amortization) of Discounts and Premiums, Investments at other companies
Other financials
Where this comes from
Reported directly by Kiniksa Pharmaceuticals International, plc in its filing.
Tagged under the XBRL concept us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments.
The source filing: Kiniksa Pharmaceuticals International, plc’s 10-Q, filed July 28, 2026.
- Filed
- Jul 28, 2026, 4:17 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-087545
| Line item | Six Months Ended / June 30, 2026 | Six Months Ended / June 30, 2025 |
|---|---|---|
| Depreciation and amortization expense | 940 | 703 |
| Share-based compensation expense | 21,692 | 16,624 |
| Non-cash lease expense | 2,005 | 1,759 |
| Net amortization of premiums and accretion of discounts on short-term investments | 1,395 | (589) |
| Net gain on disposal of property and equipment | (32) | (24) |
| Deferred income taxes | 7,184 | 5,637 |
| Changes in operating assets and liabilities: | ||
| Prepaid expenses and other current assets | (5,523) | (12,195) |
Item 1. Financial Statements (unaudited)
FAQ
- What is Kiniksa Pharmaceuticals International, plc's accretion (amortization) of discounts and premiums, investments?
- Kiniksa Pharmaceuticals International, plc (KNSA) reported accretion (amortization) of discounts and premiums, investments of -$93K in Q2 2026.
- How has Kiniksa Pharmaceuticals International, plc's accretion (amortization) of discounts and premiums, investments changed year-over-year?
- Kiniksa Pharmaceuticals International, plc's accretion (amortization) of discounts and premiums, investments decreased by 111.0% year-over-year, from $844K to -$93K.
- What is the long-term trend for Kiniksa Pharmaceuticals International, plc's accretion (amortization) of discounts and premiums, investments?
- Over 2 years (2021 to 2025), Kiniksa Pharmaceuticals International, plc's accretion (amortization) of discounts and premiums, investments has grown at a 17.5% compound annual growth rate (CAGR), from -$664K to $916K.
- What does accretion (amortization) of discounts and premiums, investments mean?
- This represents the non-cash adjustment to the carrying value of debt or investment securities resulting from the amortization of premiums or the accretion of discounts over the life of the instrument. It aligns the effective interest rate of the financial asset or liability with the stated coupon rate. Monitoring this helps analysts understand the non-cash components of interest income or expense that affect net earnings.
Ask your AI about Kiniksa Pharmaceuticals International, plc's accretion (amortization) of discounts and premiums, investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude